Use dmy dates date July 2011 PBB geneid 3643 The insulinreceptor IR is a transmembrane receptor transmembrane receptor proteomics receptor that is activated by insulin , IGF I , IGF II and belongs to the large ... MC title Ligand induced activation of the insulinreceptor a multi step process involving structural ... . ref name pmid2859121 cite journal author Ebina Y, Ellis L title The human insulinreceptor cDNA ... Malaguarnera R, Belfiore A title Proinsulin Binds with High Affinity the InsulinReceptor Isoform ... year 2012 month February pmid 22355074 doi url issn ref Biochemically, the insulinreceptor is encoded ... A, Frasca F title Insulinreceptor isoforms and insulinreceptorinsulin like growth factor receptor ... coded schematic of the insulinreceptor Upon receptor dimerisation, after Proteolysis protyolytic ... basis for the kinetic differences between the two insulinreceptor isoforms. journal Biochemical ... in the insulinreceptor and its implications for design of peptide agonists. journal PNAS volume ... CW et al. title Structure of the insulinreceptor ectodomain reveals a folded over conformation ... ligand Receptor ligand kinetics kinetics insulin IGF I has been identified in the context of the currently ... kinase receptor s, including the insulinreceptor, mediate their activity by causing the addition ... that are phosphorylated by the InsulinReceptor include a protein called IRS 1 for insulinreceptor .... Insulin binds to its receptor 1 , which, in turn, starts many protein activation cascades 2 . These include ... of the insulinreceptor is inducing glucose uptake. For this reason insulin insensitivity , or a decrease in insulinreceptor signaling, leads to diabetes mellitus type 2 the cells are unable to take ... insulinreceptor. These patients have low set, often protuberant, ears, flared nostrils, thickened ... of glycogen synthesis Glycogen synthesis is also stimulated by the insulinreceptor via IRS 1. In this case ... of the insulinreceptor complex followed by the action of insulin degrading enzyme . Most insulin ... more details
Insulinreceptor substrate IRS is an important ligand in the insulin response of human cells. IRS 1 , for example, is an IRS protein that contains a phosphotyrosine binding domain PTB domain PTB domain . In addition, the insulinreceptor contains a NPXpY protein domain domain . The PTB domain binds the NPXpY domain. Thus, the insulinreceptor binds IRS. Genes Gene IRS1 see also Insulinreceptor substrate 1 Gene IRS2 see also IRS2 Insulinreceptor substrate 2 Gene IRS3P a pseudogene Gene IRS4 References cite journal author van der Geer P, Wiley S, Pawson T title Re engineering the target specificity of the insulinreceptor by modification of a PTB domain binding site journal Oncogene volume 18 issue 20 pages 3071 5 year 1999 pmid 10340378 doi 10.1038 sj.onc.1202879 Category Coordination chemistry Category Chemical bonding de Insulin Rezeptor Substrat ... more details
PBB geneid 3480 The Insulin like Growth Factor 1 IGF 1 Receptor is a protein found on the surface of human ... 320 kDa. The receptor is a member of a family which consists of the InsulinReceptor and the Insulin ... homology between IGF 1R and the insulinreceptor. In response to ligand binding, the chains induce ... Echeverr a C, Hofmann F, Krystal GW title The insulin like growth factor I receptor kinase inhibitor ... author Klopfleisch R, Hvid H, Klose P, da Costa A, Gruber AD. title Insulinreceptor is expressed ... to at least two cell surface receptors the IGF1 Receptor IGFR , and the insulinreceptor . The IGF 1 ... it binds the insulinreceptor. Like the insulinreceptor, the IGF 1 receptor is a receptor tyrosine ... 1 activates the Insulinreceptor at approximately 0.1x the potency of insulin. Part of this signaling ... show that IGF1 binds the insulinreceptor 100 fold less well than insulin, yet that does not correlate with the actual potency of IGF1 in vivo at inducing phosphorylation of the Insulinreceptor, and hypoglycemia ..., Garan SA, Gouw AM, Voelker MA, Sternberg H, Timiras PS title Insulin like growth factor 1 receptor ... of IGF 1R and the insulinreceptor IR , especially in the regions of the ATP binding site ... figitumumab . Interactions Insulin like growth factor 1 receptor has been shown to Protein protein ... 3 protein interacts with the insulin like growth factor I receptor journal Biochem. Biophys. Res. Commun ... M year 1995 month Aug. title Localization of the insulin like growth factor I receptor binding sites ... SOCS 2 with the insulin like growth factor I receptor journal J. Biol. Chem. volume 273 issue 37 ... regulates ligand induced ubiquitination and stability of the insulin like growth factor I receptor ... for the direct interaction of the insulin like growth factor I receptor with IRS 1, Shc, and Grb10 ... M, Gustafson T A year 1998 month Mar. title Grb10 interacts differentially with the insulinreceptor, insulin like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology ... more details
A, Francke U title Chromosomal mapping of the gene for the type II insulin like growth factor receptor cation independent mannose 6 phosphate receptor in man and mouse journal Genomics volume 3 issue ... is a multifunctional protein receptor biochemistry receptor that binds insulin like growth factor 2 ... Insulin like growth factor 2 receptor has been shown to Protein protein interaction interact with M6PRBP1 ... author Hawkes C, Kar S title The insulin like growth factor II mannose 6 phosphate receptor structure ... M title Expression of insulin like growth factors I and II and their receptor mRNAs in primary ... Insulin like growth factor II receptor as a multifunctional binding protein journal Nature volume 329 ... 6 phosphate insulin like growth factor II receptor locus in human hepatocellular tumors journal ... to amino acids 1508 1566 in repeat 11 of the mannose 6 phosphate insulin like growth factor II receptor ... 6 Phosphate Insulin like Growth Factor II Receptor Targets the Urokinase Receptor to Lysosomes ...PBB geneid 3482 about the cation independent mannose 6 phosphate receptor the cation dependent receptor cation dependent mannose 6 phosphate receptor In the fields of biochemistry and cell biology , the insulin like growth factor 2 receptor IGF2R , also called the cation independent mannose 6 phosphate receptor CI MPR is a protein that in humans is encoded by the IGF2R gene . ref name pmid2963003 cite ... mannose 6 phosphate receptor. Cloning and sequence of the full length cDNA and expression of functional receptor in COS cells journal J. Biol. Chem. volume 263 issue 5 pages 2553 62 year 1988 month February ... of the mannose 6 phosphate receptor . Binding to IGF2 is mediated through one of the repeats, while ... device for mannose 6 phosphate receptor trafficking journal Cell volume 93 issue 3 pages 433 43 year ... 6 phosphate receptor cytoplasmic domain by 47 kDa tail interacting protein journal Proc. Natl. Acad ... pnas.160251397 url ref See also Cluster of differentiation IGF 1 Receptor Mannose 6 phosphate receptor ... more details
PBB geneid 51289 Relaxin insulin like family peptide receptor 3 , also known as RXFP3 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP3 relaxin insulin like family peptide receptor 3 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 51289 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text See also Relaxin receptor References reflist External links cite web url http www.iuphar db.org GPCR ReceptorDisplayForward?receptorID 3024 title Relaxin Family Peptide Receptors RXFP3 accessdate author authorlink coauthors date format work IUPHAR Database of Receptors and Ion Channels publisher International Union of Basic and Clinical Pharmacology pages language archiveurl archivedate quote Further reading refbegin 2 PBB Further reading citations cite journal author Bathgate RA, Ivell R, Sanborn BM, et al. title Receptors for relaxin family peptides. journal Ann. N. Y. Acad. Sci. volume 1041 issue pages 61 76 year 2005 pmid 15956688 doi 10.1196 annals.1282.010 cite journal author Bathgate RA, Ivell R, Sanborn BM, et al. title International Union of Pharmacology LVII recommendations for the nomenclature of receptors for relaxin family peptides. journal Pharmacol. Rev. volume 58 issue 1 pages 7 31 year 2006 pmid 16507880 doi 10.1124 pr.58.1.9 cite journal author Matsumoto M, Kamohara M, Sugimoto T, et al. title The novel G protein coupled receptor SALPR shares sequence similarity with somatostatin and angiotensin ... of relaxin 3 INSL7 as an endogenous ligand for the orphan G protein coupled receptor GPCR135 journal ... cite journal author Liu C, Chen J, Kuei C, et al. title Relaxin 3 insulin like peptide 5 chimeric peptide, a selective ligand for G protein coupled receptor GPCR 135 and GPCR142 over leucine rich repeat containing G protein coupled receptor 7 journal Mol. Pharmacol. volume 67 issue 1 pages 231 ... more details
PBB geneid 122042 Relaxin insulin like family peptide receptor 2 , also known as RXFP2 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP2 relaxin insulin like family peptide receptor 2 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 122042 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text The receptors for glycoprotein hormones such as follicle stimulating hormone FSH see MIM 136530 and thyroid stimulating hormone TSH see MIM 188540 are G protein coupled, 7 transmembrane receptors GPCRs with large N terminal extracellular domains. Leucine rich repeat LRR containing GPCRs LGRs form a subgroup of the GPCR superfamily. supplied by OMIM ref name entrez See also Relaxin receptor References reflist External links cite web url http www.iuphar db.org GPCR ReceptorDisplayForward?receptorID 3023 title Relaxin Family Peptide Receptors RXFP2 accessdate author authorlink coauthors date format work IUPHAR Database of Receptors and Ion Channels publisher International Union of Basic and Clinical Pharmacology ... insulin like peptide activates the LGR8 receptor important in testis descent journal J. Biol. Chem ... receptor binding surface of insulin like peptide 3 journal J. Biol. Chem. volume 281 issue 38 pages ... A, Feng S, et al. title T222P mutation of the insulin like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane journal ... ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2 ... receptor pair in human cryptorchidism journal J. Clin. Endocrinol. Metab. volume 88 issue 9 pages ... of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique ... insulin like peptide 3 journal Mol. Endocrinol. volume 21 issue 7 pages 1699 712 year 2007 pmid ... more details
PBB geneid 59350 Relaxin insulin like family peptide receptor 1 , also known as RXFP1 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP1 relaxin insulin like family peptide receptor 1 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 59350 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text See also Relaxin receptor References reflist External links cite web url http www.iuphar db.org GPCR ReceptorDisplayForward?receptorID 3022 title Relaxin Family Peptide Receptors RXFP1 accessdate author authorlink coauthors date format work IUPHAR Database of Receptors and Ion Channels publisher International Union of Basic and Clinical Pharmacology pages language archiveurl archivedate quote Further reading refbegin 2 PBB Further reading citations cite journal author Bathgate RA, Ivell R, Sanborn BM, et al. title .... title H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both ... Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates ... JA, et al. title Gene expression pattern and immunoreactive protein localization of LGR7 receptor ..., Samuel CS, et al. title Increased expression of the relaxin receptor LGR7 in human endometrium during ..., Kuei C, et al. title Relaxin 3 insulin like peptide 5 chimeric peptide, a selective ligand for G protein coupled receptor GPCR 135 and GPCR142 over leucine rich repeat containing G protein coupled receptor ... rich repeat containing G protein coupled receptor 7 journal Clin. Exp. Pharmacol. Physiol. volume 31 ... coupled receptor 7 journal J. Biol. Chem. volume 280 issue 14 pages 14051 6 year 2005 pmid 15695505 ... relaxin receptor increases the transcription of IGFBP 1 and prolactin in human decidual and endometrial ... author Bond CP, Parry LJ, Samuel CS, et al. title Increased expression of the relaxin receptor LGR7 ... more details
PBB geneid 339403 Relaxin insulin like family peptide receptor 4 , also known as RXFP4 , is a human G protein coupled receptor . ref name entrez cite web title Entrez Gene RXFP4 relaxin insulin like family peptide receptor 4 url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 339403 accessdate ref The PBB Summary template is automatically maintained by Protein Box Bot. See Template PBB Controls to Stop updates. PBB Summary section title summary text GPR100 is a member of the rhodopsin family of G protein coupled receptors GPRs Fredriksson et al., 2003 . supplied by OMIM ref name entrez See also Relaxin receptor References reflist External links cite web url http www.iuphar db.org GPCR ReceptorDisplayForward?receptorID 3037 title Relaxin Family Peptide Receptors RXFP4 accessdate author authorlink coauthors date format work IUPHAR Database of Receptors and Ion Channels publisher International Union of Basic and Clinical Pharmacology pages language archiveurl archivedate quote Further reading refbegin 2 PBB Further reading citations cite journal author Bathgate RA title Receptors for relaxin family peptides journal Ann. N. Y. Acad. Sci. volume 1041 issue pages 61 76 year 2005 pmid 15956688 doi 10.1196 annals.1282.010 author separator , author2 Ivell R author3 Sanborn BM display authors 3 last4 Sherwood first4 OD last5 Summers first5 RJ cite journal author Bathgate RA title International Union of Pharmacology LVII recommendations for the nomenclature ... of G protein coupled receptor genes from the human genome sequence journal FEBS Lett. volume ... bradykinin receptor journal Br. J. Pharmacol. volume 140 issue 5 pages 932 8 year 2004 pmid 14530218 ... Schi th first5 Helgi B cite journal author Liu C title Relaxin 3 insulin like peptide 5 chimeric peptide, a selective ligand for G protein coupled receptor GPCR 135 and GPCR142 over leucine rich repeat containing G protein coupled receptor 7 journal Mol. Pharmacol. volume 67 issue 1 pages 231 40 year ... more details
, Kim KS, Lee KU, Lee IK title Glucocorticoid receptor mediated repression of human insulin gene expression ... 2007 pmid 17822201 doi ref This is thought to avoid receptor downregulation downregulation of insulinreceptor s in target cells, and to assist the liver in extracting insulin from the blood. ref name ... elevated blood glucose levels. Activation of insulinreceptor s leads to internal cellular mechanisms ... up the insulinreceptor in cell membranes have been identified, and the structures of the interior ... human body. Insulin binds to the extracellular portion of the alpha subunits of the insulinreceptor. This, in turn, causes a conformational change in the insulinreceptor that activates the kinase ..., endocytosis and degradation of the receptor bound to insulin is a main mechanism to end ... ref Degradation Once an insulin molecule has docked onto the receptor and effected its action, it may ... normally involves endocytosis of the insulinreceptor complex, followed by the action of insulin ...About the insulin protein uses of insulin in treating diabetes insulin therapy Distinguish inulin PBB geneid 3630 Insulin is a hormone , produced by the pancreas , which is central to regulating carbohydrate and fat metabolism in the body. Insulin causes cells in the liver , muscle , and fat cell fat tissue to take up glucose from the blood , storing it as glycogen inside these tissues. Insulin stops ... disorder diabetes mellitus and metabolic syndrome , insulin is provided within the body ... of insulin levels fails, diabetes mellitus will result. As a consequence, insulin is used medically ... depend on external insulin most commonly Subcutaneous injection injected subcutaneously for their survival ... 2 type 2 diabetes are often insulin resistance insulin resistant and, because of such resistance, may suffer from a relative insulin deficiency. Some patients with type 2 diabetes may eventually require insulin if other medications fail to control blood glucose levels adequately. Over 40 of those with Type ... more details
receptor binding, but blocked the formation of insulin protein dimer dimer s and hexamers ... insulin, branded Humulin 1985 Axel Ullrich sequences the human insulinreceptor 1988 Novo Nordisk ...refimprove date March 2010 An insulin analog is an altered form of insulin , different from any occurring in nature, but still available to the human body for performing the same action as human insulin ... of insulin can be changed to alter its ADME absorption, distribution, metabolism, and excretion characteristics. Officially, the U.S. Food and Drug Administration FDA refers to these as insulinreceptor ligands , although they are more commonly referred to as insulin analogs. These modifications have been used to create two types of insulin analogs those that are more readily absorbed from the injection site and therefore act faster than natural insulin injected subcutaneously, intended to supply the bolus level of insulin needed after a meal and those that are released slowly over a period of between 8 and 24 hours, intended to supply the basal level of insulin for the day. Insulin analog was first manufactured by Eli Lilly and Company . Animal insulin The amino acid sequence for insulin is almost the same in different mammals. Porc ine insulin has only a single amino acid variation from the human variety, and cattle bovine insulin varies by three amino acids. Both are active on the human Receptor biochemistry receptor with approximately the same strength. Prior to the introduction of biosynthetic human insulin, insulin derived from sharks was widely used in Japan. Even insulin ... reactions in a tiny number of people, as can genetically engineered human insulin. This is usually caused by the preservatives used in the insulin rather than the insulin molecule itself. Biosynthetic human insulin has largely replaced animal insulin. With the advent of high pressure liquid chromatography ... a maximum purity level of 97 , which raises questions about the claim of synthetic insulin s purity ... more details
Pulsatile insulin , sometimes called metabolic activation therapy , or cellular activation therapy describes in a literal sense the intravenous injection of insulin in pulses versus continuous infusions. Injection of insulin in pulses mimics the physiological secretions of insulin by the pancreas into the portal ... secretions of insulin correspond to the intake of food. The pancreas will secrete variable amounts of insulin based upon the amount of food consumed basically speaking, the more food that is consumed, the more insulin the pancreas will secrete among other factors. The majority of available experimental evidence suggests a more potent hypoglycemic effect of pulsatile insulin in comparison to continuous insulin infusion. Continuous exposure to insulin and glucagon is known to decrease the hormones ... action of steady state levels of insulin, while pulsatile hormone secretion may allow recovery of Receptor biochemistry receptor affinity and numbers for insulin. Intermittent intravenous insulin administration with peaks of insulin concentrations may enhance suppression of gluconeogenesis ... at the University of California, Davis , was the pioneer of using pulsatile insulin in the treatment ..., inadequate insulin delivery, and insulin resistance. Pulsatile Insulin and the Liver Normally, insulin is secreted from the pancreas in pulses into the portal vein which brings blood into the liver in variable amounts, closely related to ingestion of meals. For induction and maintenance of insulin ... , and pyruvate kinase , the hepatocytes require a defined insulin level 200 500 U ml ... diabetic subjects, portal insulin concentrations are twofold to threefold greater than those in the peripheral circulation. During the first pass through the liver, 50 of the insulin is removed, strongly ... and the pancreas. The insulin retained by the hepatocytes may itself be essential for the long term effects of insulin on hepatic glucose metabolism as well as growth and de novo enzyme synthesis. Following ... more details
Image Pancreas insulin oscillations.svg thumb right 250px Insulin release from pancreas is pulsatile with a period of 3 6 minutes. ref name hellman The insulin concentration in blood increases after meals and gradually returns to basal levels during the next 1 2 hours. However, the basal insulin level ... B, Gylfe E, Grapengiesser E, Dansk H, Salehi A title Insulin oscillations clinically important rhythm. Antidiabetics should increase the pulsative component of the insulin release language Swedish ... are believed to be important for insulin sensitivity by preventing downregulation of insulinreceptor s in target cells. ref name hellman Such downregulation underlies insulin resistance, which is common in type 2 diabetes . It would therefore be advantageous to administer insulin to diabetic patients in a manner mimicking the natural oscillations. ref name hellman The insulin oscillations are generated by pulsatile release of the hormone from the pancreas . Insulin originates from beta ... synchronization both within and among the islets of Langerhans. Image Insulin oscillations.svg thumb right 250px Pulsatile insulin release from single beta cells is synchronized in each islet of Langerhans as well as among all islets in the pancreas. Mechanism Pulsatile insulin secretion from ... 6 min . ref name hellman Image Insulin oscillations coordination.svg thumb left 150px Coordination of pulsatile insulin release. In addition to gap junctions, coordination is done by ATP signaling. Pulsatile insulin release from the entire pancreas requires that secretion is synchronized between 1 ... in release of ATP from the beta cells. The released ATP in turn binds to Receptor biochemistry receptors ... the cells within the islet. This signal is believed to entrain pulsatile insulin release from the islets into a common pancreatic rhythm. ref name hellman Clinical significance The insulin oscillations ... is a major insulin target. Disturbances of the insulin oscillations occur early in type 2 diabetes ... more details
noble.html title Insulin Lispro A Fast Acting Insulin Analog accessdate 2007 06 08 work ref Insulin lispro has one primary advantage over regular insulin for postprandial glucose control. It has a shortened delay of onset, allowing slightly more flexibility than regular insulin, which requires ... with a longer acting insulin for good glycemic control. References references External links http ... of Humalog Crystals February 22, 2010 Oral hypoglycemics and insulin analogs DEFAULTSORT Insulin Lispro Category Eli Lilly and Company Category Insulin therapies Category Diabetes Category Human ... Insulinpr parat Insulin lispro nl Insuline lispro pl Insulina lispro sv Insulin lispro ... more details
insulinreceptor ligand s so named because they are not technically insulin, rather they are analogues ... a human cell membrane insulinreceptor. 1988 Novo Nordisk produces recombinant biosynthetic human ...About uses of insulin in treating diabetes the insulin protein insulin Image Suckale08 fig3 glucose insulin ... hormone insulin blue in humans during the course of a day containing three meals. In addition, the effect of a sucrose sugar rich versus a starch rich meal is highlighted. Insulin therapy is the treatment of diabetes by administration of exogenous insulin . Insulin is used medically to treat ... on external insulin most commonly Injection medicine Subcutaneous injection injected subcutaneously ... mellitus type 2 Type 2 diabetes mellitus are insulin resistance insulin resistant , have relatively low insulin production, or both certain patients with Type 2 diabetes may eventually require insulin ... of Insulin Preparations ref cite web url https secure.pharmacytimes.com lessons 200510 03.asp title Pharmacist s Guide to Insulin Preparations A Comprehensive Review author Takiya, Lisa, Dougherty ... Lysine Thr Threonine Ile Isoleucine Glu Glutamine Gly Glycine Insulin is required for all animal life ... across evolutionary time. Insulin must be administered to patients who experience such a deprivation. Clinically, this condition is called diabetes mellitus type 1 . The initial sources of insulin for clinical use in humans were cow , horse , pig or fish pancreases. Insulin from these sources is effective in humans as it is nearly identical to human insulin three amino acid difference in bovine insulin, one amino acid difference in porcine . Differences in suitability of beef , pork , or fish derived insulin for individual patients have historically been due to lower preparation purity resulting in allergic reactions to the presence of non insulin substances. Though purity has improved steadily ... types of allergic reactions have also been known to occur in response to synthetic human insulin ... more details
factors include Genetic factors inherited component Family history with type 2 diabetes Insulinreceptor ... kinase activity at the insulinreceptor level and exaggerated intracellular calcium concentration ...Expert subject Medicine date December 2009 Infobox disease Name Insulin resistance Image Caption DiseasesDB ICD10 ICD9 ICDO OMIM MedlinePlus eMedicineSubj med eMedicineTopic 1173 MeshName Insulin Resistance MeshNumber C18.452.394.968.500 Insulin resistance IR is a physiological condition where the natural hormone insulin becomes less effective at lowering blood sugars. The resulting increase in blood ... conditions. Certain cell types such as fat and muscle cell biology cells require insulin to absorb glucose. When these cells fail to respond adequately to circulating insulin, blood glucose levels ... of insulin. This normal reduction in the liver s glucose production may not occur in people with insulin ... www.sciencedaily.com work accessdate ref Insulin resistance in muscle and fat cells reduces glucose ... insulin resistance in liver cells results in reduced glycogen synthesis and storage and a failure to suppress glucose production and release into the blood. Insulin resistance normally refers to reduced glucose lowering effects of insulin. However, other functions of insulin can also be affected. For example, insulin resistance in adipose tissue fat cells reduces the normal effects of insulin on lipids ... plasma . Elevated blood fatty acid concentrations associated with insulin resistance and diabetes ... to elevated blood glucose levels. High plasma levels of insulin and glucose due to insulin resistance are a major component of the metabolic syndrome . If insulin resistance exists, more insulin ... insulin resistance article.htm title www.medicinenet.com work accessdate ref Signs and symptoms Original research section discuss Talk Insulin resistance Original research in symptoms ... may not be found with all people diagnosed with insulin resistance. Fatigue. Brain fogginess ... more details
Image Insulin pen.JPG thumb 400 px Two types of modern, pre filled insulin syringes. An insulin pen is used to inject insulin for the treatment of diabetes . It is composed of an insulin cartridge integrated ... to deliver the dose. Types of pens A number of companies make insulin pens including Novo Nordisk , Aventis ... produce pens for most of their insulins, including Insulin aspart NovoLog NovoRapid , Insulin lispro Humalog , Insulin detemir Levemir and Insulin glargine Lantus . pendiq does not produce insulin and the pendiq pen can work with most of the common insulin cartridges. ref http www.pendiq.com ... pen uses a replaceable insulin cartridge. When the insulin cartridge is empty, the empty cartridge ... comes pre filled with insulin, and when the insulin cartridge or reservoir is empty, the entire unit is discarded. Most brands of insulin are now available for use in pens, these include NovoLog ... Lilly and Company Use Insulin pens are used by 90 to 95 of insulin treated patients in Europe, Asia ... underutilized but growing in use in the United States. Insulin pens offer several significant advantages over insulin syringes ease of handling, accuracy, and more discreet to use. To use ... Insulin pens have a number of advantages More convenient and easier to transport than traditional ... by insertion into a vial of insulin before a second insertion into the skin A memory of 195 injections ... with the traditional syringe , two different insulins cannot be mixed by the user in an insulin pen. ref http www.paralumun.com diabetespen.htm Diabetes Insulin Pen ref On the other hand, some of the newest types of insulin cannot be mixed at all. In addition, using pens and pen needles is usually more expensive than using the traditional vial and syringe method insurance coverage for insulin pens ... group insulinpenusers Insulin Pen Users group http www.diabetes.co.uk insulin diabetes and insulin pens.html Insulin Pen Reviews See also Insulin pump Syringe Standard U 100 insulin syringes Insulin syringe ... more details
Multiple issues primarysources March 2010 unreferenced December 2009 expert March 2010 NPH insulin or neutral ... insulin , is an intermediate acting insulin given to help control the blood sugar level of those with diabetes. NPH was created in 1936 when Novo Nordisk Nordisk formulated isophane porcine insulin by adding neutral protamine to regular insulin. This is a suspension of crystalline zinc insulin ... duration of action, meaning longer than that of regular insulin, and shorter than ultralente , Insulin glargine glargine or Insulin detemir detemir . History Hans Christian Hagedorn 1888 1971 and August Krogh 1874 1949 obtained the rights for insulin from Frederick Banting Banting and Charles ... and B. Norman Jensen discovered that the effects of injected insulin could be prolonged by the addition of protamine obtained from the milt or semen of river trout. The insulin would be added to the protamine ... bok insulin, a mixture of zinc , protamine and porcine insulin. This mixture only needed to be shaken before injection. In 1946, Nordisk was able to form crystals of protamine and insulin and marketed it in 1950 as NPH insulin. NPH insulin has the advantage that it can be mixed with an insulin that has ... on the market today, because manufacturers sell a variety of premixed insulin formulations. However ... injected subcutaneously, and a majority of head to head comparisons with Lente insulin usually found ... replaced by synthetic, Recombinant DNA recombinant human insulin. Synthetic human insulin is also complexed with protamine to form NPH. NPH insulin is cloudy and has an onset of 3 4 hours. Its peak is 4 9 hours and its duration is about 15 hours. Administration NPH insulin may be combined with faster acting insulin to allow more accurate dosing and better blood sugar level control. When administered this way, the two insulin types will normally be combined in the same syringe. NPH and fast acting insulin bind when mixed, so they should not be combined until it is time to inject. Patients are instructed ... more details
Drugbox verifiedrevid 476995027 IUPAC name Recombinant human insulin Clinical data tradename pregnancy ... Ref chemspidercite correct chemspider ChemSpiderID NA Chemical data C H N O S Insulin degludec is a ultralong acting basal insulin analogue being developed by Novo Nordisk . It is injected subcutaneously ... acting insulins such as insulin glargine and insulin detemir . ref name dic cite web url http www.diabetesincontrol.com ... weekly insulin&catid 1&Itemid 8 title Good News for Novo s Thrice Weekly Insulin work DiabetesInControl.com ... 2010 06 25 novo s degludec insulin as effective as lantus with fewer doses.html title Novo s Degludec Insulin as Effective as Lantus With Fewer Doses work Bloomberg Businessweek author Schwartzkopff, Frances date 2010 06 25 accessdate 2010 11 07 ref Insulin degludec is a modified insulin that has one single amino acid deleted in comparison to human insulin, and is conjugated to palmitic acid at the amino ... insulin degludec needed to take significantly smaller doses of basal rate basal insulin than those taking insulin glargine, while achieving similar blood glucose levels. Insulin degludec also has the ability ...?cid med&drugid 20805&drugname Insulin Glargine SubQ&monotype monograph&secid 3 title Monograph Insulin Glargine Dosage & Administration work American Society of Health System Pharmacists, Inc ... acting basal with rapid acting mealtime control from insulin aspart . This 2 component insulin ... medscape cite news url http www.medscape.com viewarticle 724316 title Novel Ultralong Acting Insulin as Effective as Insulin Glargine author Lowry, Fran work Medscape accessdate 2010 11 07 ref blockquote Insulin degludec has been filed for registration in the United States. ref name novo cite web url ... the insulin analog in 2013. ref name reuters2 cite news url http www.reuters.com article idUSLDE69Q13H20101027?feedType RSS&feedName rbssHealthcareNews work Reuters title New Novo insulin fails to knock ... drugportal dpdirect.jsp?name Insulin degludec U.S. National Library of Medicine Drug Information ... more details
no footnotes date March 2010 refimprove date March 2010 An insulin port functions as a medication delivery channel directly into the subcutaneous tissue the tissue layer located just beneath the skin . When applying the injection port, an insertion needle guides a soft cannula a small, flexible tube under the skin. Once applied, the insertion needle is removed and only the soft cannula remains below the skin, acting as the gateway into the subcutaneous tissue. To inject through an insulin port the needle of a syringe or insulin pen is used. It is usually used to deliver insulin through the use of an insulin pump . The needle remains above the surface of the skin, while the medication is immediately delivered through the soft cannula and into the subcutaneous tissue. References http spectrum.diabetesjournals.org cgi content abstract 21 3 197 DiabetesJournals.org See also Injection port DEFAULTSORT Insulin Port Category Catheters Category Diabetes related supplies and medical equipment Category Insulin therapies ... more details
More footnotes date March 2010 Image Insulin pump and infusion set.JPG thumb right 300px Insulin pump ... set shown here removed from the pump . Image Insulin pump reservoir.jpg thumb right 300px Filling an insulin pump reservoir. Left to right 1 Reservoir in sterile packaging. 2 Filling the reservoir ... right 300px Image super bolus.JPG thumb right 300px The insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus , also known as continuous Subcutaneous tissue subcutaneous insulin infusion therapy. The device includes the pump itself including controls, processing module, and batteries a disposable reservoir for insulin inside the pump a disposable ... system to interface the insulin reservoir to the cannula. An insulin pump is an alternative to multiple daily injections of insulin by syringe Standard U 100 insulin syringes insulin syringe or an insulin pen and allows for intensive insulin therapy when used in conjunction with blood glucose monitoring and carb counting. Setting up howto date March 2012 To use an insulin pump, the reservoir must first be filled with insulin. Some pumps use prefilled cartridges that are replaced when empty. Most, however, are filled with the insulin prescribed for the user usually Insulin glulisine Apidra , Insulin lispro Humalog , Insulin aspart Novolog or Regular . Setting up includes Opening a new sterile empty pump reservoir Withdrawing the plunger Inserting the needle into a vial of insulin Injecting the air from the reservoir into the vial to prevent a vacuum forming in the vial as insulin is withdrawn Drawing insulin into the reservoir with the plunger, and then removing the needle Squirting out ... set tubing Installing the assembly into the pump and priming the tubing pushing insulin and any ... accidental insulin delivery Attaching to the infusion site and priming the cannula if a new set has been inserted . Dosing An insulin pump allows the replacement of slow acting insulin for basal needs ... more details
Drugbox Verifiedfields changed verifiedrevid 464363066 IUPAC name drug name Insulin Detemir Clinical data tradename Drugs.com drugs.com monograph insulin detemir MedlinePlus a606012 pregnancy AU A B1 B2 ... data C 267 H 402 N 64 O 76 S 6 molecular weight 5913 Insulin detemir is a long acting human insulin analogue for maintaining the basal level of insulin. Novo Nordisk markets it under the trade name Levemir . It is an insulin analogue in which a fatty acid myristic acid is bound to the lysine ... Insulin Detemir With NPH Insulin as Add On Therapy to Oral Glucose Lowering Drugs in Insulin Na ve ... , but the proportion achieving this without hypoglycemia was higher with insulin detemir than with NPH insulin 26 vs. 16 , P 0.008 . Compared with NPH insulin, the risk for all hypoglycemia with insulin ... was 1.2 kg with insulin detemir and 2.8 kg with NPH insulin P 0.001 , and the difference in baseline adjusted final weight was 1.58 P 0.001 . In short, it was found that insulin detemir reduced Hemoglobin A1C to target levels of 7.0 for 70 of patients, similar to human basal insulin NPH, but without ... to NPH insulin, the The Levemir package insert states the following disclaimer blockquote LEVEMIR ... represent true differences in the effects of LEVEMIR and NPH insulin is not known, since these trials ... In addition, the safety and efficacy of insulin detemir Levemir in real life clinical practice was evaluated ... insulin after learning that 129,000 stolen vials reappeared and were being sold in the U.S. ..., Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes Rury R. Holman, M.B., Ch.B., F.R.C.P. ... , Insulin analogues insulin detemir and insulin aspart versus traditional human insulins NPH insulin and regular human insulin in basal bolus therapy for patients with Type 1 diabetes, Journal Diabetologia ... www.levemir us.com prescribing information.pdf Levemir Package Insert Oral hypoglycemics and insulin analogs DEFAULTSORT Insulin Detemir Category Insulin therapies de Insulin detemir nl Insuline detemir ... more details
Drugbox Verifiedfields changed verifiedrevid 458271727 IUPAC name Recombinant human insulin Clinical data tradename Drugs.com drugs.com monograph insulin glargine MedlinePlus a600027 pregnancy AU A B1 ... g mol Insulin glargine , marketed by Sanofi Aventis under the name Lantus , is a long acting basal insulin analogue , given once daily to help control the blood sugar level of those with diabetes . It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 ... basal insulin secretion of non diabetic pancreatic beta cells. Sometimes, in type 2 diabetes ... insulin , it can offer moderate control of serum glucose levels. In the absence of endogenous insulin ... latent autoimmune diabetes of adults in late stage Lantus needs the support of fast acting insulin ... of action pharmacodynamics Insulin glargine have substitution of glycine for asparagine at A21 and two ..., resulting in a slow, peakless dissolution and absorption of insulin from the site of injection. ref name Bolli cite journal author Bolli, G. et. al. year 1999 title Insulin analogues and their potential ... , when a physiologic pH approximately 7.4 is achieved the increase in pH causes the insulin to come out of solution resulting in the formation of higher order aggregates of insulin hexamers. The higher order aggregation slows the dissociation of the hexamers into insulin monomers, the functional and physiologically active unit of insulin. This gradual process ensures that small amounts of Lantus ... insulin preparations Unlike some other longer acting insulins, Lantus must not be diluted or mixed with other insulin or solution in the same syringe. ref American Diabetes Association. 2003 . Position statement Insulin administration. Diabetes Care 26 Suppl. 1 , 121 124 ref However, this restriction ... of Texas Childrens Hospital. ref Effects of Mixing Glargine and Short Acting Insulin Analogs ... of Lantus and insulin pen manufacturing at the location Frankfurt H chst lied at 700 Mio. . In 2008 ... more details
expert date March 2010 Drugbox Verifiedfields changed verifiedrevid 464363109 IUPAC name image Insulin Aspart Structural Formula.gif drug name Insulin Aspart Clinical data tradename Drugs.com drugs.com monograph insulin aspart MedlinePlus a605013 pregnancy AU A B1 B2 B3 C D X pregnancy US C pregnancy ... H 381 N 65 O 79 S 6 molecular weight 5825.8 g mol A fast acting insulin analog marketed by Novo Nordisk as NovoLog NovoRapid is a man made form of human insulin. A single amino acid has been slightly changed in its molecular structure. This change helps the fast acting insulin analog absorb quickly into the bloodstream. As a result, it starts working in minutes, which allows you to take insulin and eat right away. Fast acting insulin analogs are considered to act similar to the way insulin is released ... allows the patient to adjust their insulin according to any changes in their eating habits. ref name ... FAQ accessdate 2011 work ref The safety and efficacy of Insulin aspart NovoLog NovoRapid in real life ... a faster acting insulin. The sequence was inserted into the yeast genome, and the yeast expressed the insulin analogue, which was then harvested from a bioreactor . According to JDRF, insulin ... 2000. cn date February 2011 Chemical properties The components of insulin aspart are as follows Metal ... chloride 0.58 mg mL . The pH of insulin aspart is 7.2 7.6. ref name Pharmaceutical Biotechnology .... However, as with all insulin, these numbers are based on averages, and vary between individuals due ... FDA. NovoLog Insulin Aspart rDNA origin Injection. 7 June 2000. http www.fda.gov CDER foi label 2000 20986lbl.pdf ref Temperature It has been debated whether or not insulin aspart or NovoLog NovoRapid should be refrigerated. Recent studies have shown that there is no difference, however insulin should ... boiling state, and separate. This can change the potency of the insulin, and it would no longer be as effective ... Novolog insulin aspart rDNA origin injection accessdate 2010 10 work ref NovoLog FlexPen , vials and cartridges ... more details
Inhalable insulin was available from September 2006 to October 2007 in the United States as a new method of delivering insulin , a drug used in the treatment of diabetes mellitus diabetes , to the body. After the withdrawal of the only inhalable formulation, all currently available insulin formulations ... cite news author Justin Gillis title Inhaled Form of Insulin Is Approved url http pqasb.pqarchiver.com ... Jan 28 2C 2006&author Justin Gillis&desc Inhaled Form of Insulin Is Approved date January 28, 2006 ... , a powdered form of recombinant human insulin, delivered through an inhaler into the lungs where it is absorbed. Insulin has also been known to help patients with breast cancer, namely women. ref name FDAapproval cite web title FDA Approves First Ever Inhaled Insulin Combination Product for Treatment ... 1 diabetics still need to take a longer acting basal insulin by injection. ref name BBCnews cite news title Diabetes inhaler rejected for NHS Insulin that can be inhaled rather than injected has been ... that inhaled insulin appears to be as effective, but no better than injected short acting insulin ... and cost effectiveness of inhaled insulin in diabetes mellitus a systematic review and economic evaluation ... for daily injections among diabetics. History Insulin was introduced by Banting and Best from the University ... insulin in 1924. ref name washingtonpost Years of failure followed until scientists realized they might be able to use new technologies to turn insulin into a concentrated powder with particles ... insulin can effectively reach the lung capillaries where it is absorbed. ref cite web title Inhalational Insulin Therapy url http insulin news.com inhalable insulin.asp year 2005 publisher Insulin News.com accessdate 2007 10 22 archiveurl http web.archive.org web 20070930084403 http insulin news.com ... testing and formulating inhalable insulin. ref name washingtonpost Once concrete methods were developed ... is a form of inhalable insulin developed by Pfizer . ref name FDAapproval cite web title FDA Approves ... more details
Encyclopedia
top
